AP Biosciences (ROCO:6945) Total Equity: NT$1,271.11 Mil (As of Dec. 2025)


ROCO:6945 AP Biosciences Inc ROCO:6945
14 GF Score
Price NT$112.00
! 1 Warning Sign
View Full Analysis

What is AP Biosciences Total Equity?

AP Biosciences ROCO:6945 14 Total Equity is NT$1,271.11 Mil as of Dec. 2025. GuruFocus rates ROCO:6945 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

AP Biosciences's total equity for the quarter that ended in Dec. 2025 was NT$1,271.11 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AP Biosciences Total Equity Historical Data

* Premium members only.

The historical data trend for AP Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences Total Equity Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 558.20 1,098.66 784.11 1,622.76 1,271.11

AP Biosciences Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 1,622.76 1,461.10 1,337.63 1,271.11
ROCO:6945
14GF Score
AP Biosciences Inc ROCO:6945
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AP Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AP Biosciences's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1365.33-94.222
=1,271.11

AP Biosciences's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1365.33-94.222
=1,271.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$1,271.11 Mil mean?
AP Biosciences (ROCO:6945) has a Total Equity of NT$1,271.11 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for AP Biosciences and its competitors.
Is AP Biosciences' Total Equity too high?
AP Biosciences' current Total Equity is NT$1,271.11 Mil. Overall, AP Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does AP Biosciences' Total Equity compare to VRTX and REGN?
AP Biosciences' Total Equity of NT$1,271.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for AP Biosciences and its competitors. AP Biosciences's current Total Equity is NT$1,271.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AP Biosciences stock overvalued right now?
AP Biosciences (ROCO:6945) has a current Total Equity of NT$1,271.11 Mil. The current Total Equity is NT$1,271.11 Mil. AP Biosciences' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For AP Biosciences (ROCO:6945), the current Total Equity is NT$1,271.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AP Biosciences Business Description

Address No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
14GF Score

Get the complete analysis for ROCO:6945

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$112.00
Price